Major adaptations of prostate cancer to the inhibition of AR signaling are counterbalanced enhancement of AR signaling through AR overexpression, gene amplification, activating mutations, and expression of ligand-independent variants (10, 11). This evidence concerns the gene AR and prostate cancer.